Dr Kinta M Parker, PHD | |
775 2nd St, Helena, AL 35080-3209 | |
(205) 664-9990 | |
(205) 664-8882 |
Full Name | Dr Kinta M Parker |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 775 2nd St, Helena, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285714923 | NPI | - | NPPES |
890012330 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 688 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kinta M Parker, PHD 775 2nd St, Helena, AL 35080-3209 Ph: (205) 664-9990 | Dr Kinta M Parker, PHD 775 2nd St, Helena, AL 35080-3209 Ph: (205) 664-9990 |
News Archive
Diffuse idiopathic skeletal hyperostosis is a common but often unrecognized systemic disorder observed mainly in elderly people. All papers related to DISH demonstrate a consistent and marked increase of the disease with advancing age. Various local structural lesions such as oropharyngeal tumors, vascular pathologies, retropharyngeal abscesses, and anterior cervical osteophytes may lead to mechanical esophageal dysphagia.
The Center for Health Value Innovation (www.vbhealth.org), the nation's premier information exchange for value-based design, today announced an alignment with the American College of Occupational and Environmental Medicine and the Integrated Benefits Institute, creating a powerful triumvirate to better articulate the value of health and productivity management (HPM).
Risk & Insurance magazine today recognized Paradigm Management Services' Chief Medical Officer and founder, 2009 Risk Innovator Awards.
Octapharma USA has received confirmation of orphan drug exclusivity from the U.S. Food and Drug Administration for wilate (von Willebrand Factor/Factor VIII Concentrate, Human), the replacement therapy developed specifically for von Willebrand Disease. The approval comes from the FDA Office of Orphan Products Development, which helps to advance the development of products that demonstrate promise for the treatment of rare diseases.
Administration of antibiotics may have caused successive outbreaks of vancomycin-resistant enterococci in a Greek neonatal intensive care unit, according to a study in the October issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.
› Verified 4 days ago
Karli Martin, Psychologist Medicare: Medicare Enrolled Practice Location: 1109 Townhouse Rd, Helena, AL 35080 Phone: 205-621-8677 | |
Daniel A. Maddox, LPC Psychologist Medicare: Not Enrolled in Medicare Practice Location: 100 Creekwood Ln, Helena, AL 35080 Phone: 205-928-2515 |